Sabby Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,420
Closed -$2.82M 59
2025
Q1
$2.82M Buy
+3,420
New +$2.85M 8.31% 4
2017
Q1
Sell
-213,113
Closed -$15.7M 287
2016
Q4
$15.7M Buy
+213,113
New +$15.9M 0.91% 25
2014
Q1
Sell
-40,700
Closed -$2.27M 260
2013
Q4
$2.08M Buy
40,700
+7,544
+23% +$378K 0.13% 85
2013
Q3
$1.67M Buy
33,156
+14,934
+82% +$782K 0.11% 94
2013
Q2
$895K Buy
+18,222
New +$992K 0.06% 123

Other funds holding LLY

Sabby Management's LLY Position: Q2 2025 in Review

Sabby Management sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 3,420 shares — an estimated $2.82M sold.

Sabby Management first reported a position in LLY in Q2 2013 and held it in 5 quarters. The position peaked at $15.7M in Q4 2016. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Sabby Management reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Sabby Management sold 3,420 Eli Lilly shares in Q2 2025, an estimated $2.82M.
  • Sabby Management first reported a position in Eli Lilly in Q2 2013 and held it in 5 quarters.
  • Sabby Management's Eli Lilly position peaked at $15.7M in Q4 2016.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Sabby Management's 13F filing for Q2 2025, filed 14 Aug 2025.